What is Movantik (naloxegol)?
Movantik is a prescription medicine that contains naloxegol. It is used to treat opioid-induced constipation (OIC) in adults when constipation hasn’t been adequately managed with laxatives.
What condition does Movantik treat?
Movantik is for opioid-induced constipation related to ongoing opioid use. It targets the constipation side effect of opioids without reversing pain relief.
How does Movantik work?
Movantik uses naloxegol to block opioid receptors in the gut. This helps restore normal bowel function that opioids can slow down.
Who can take Movantik?
Movantik is used in adults with opioid-induced constipation. The exact eligibility depends on the prescriber’s assessment of your opioid regimen and constipation symptoms.
What does a typical course look like?
Movantik is taken as a daily treatment for opioid-induced constipation, with dosing determined by the prescribing clinician. How long you take it depends on how long you have opioid-related constipation and how well it controls symptoms.
What happens if it doesn’t work?
If constipation does not improve, clinicians typically reassess opioid dosing, use of other constipation treatments (such as stool softeners or stimulant laxatives), and whether an alternative therapy is needed.
Is Movantik linked to patents or exclusivity?
DrugPatentWatch.com tracks patents and legal/commercial status for many medicines. If you’re researching Movantik specifically (for example, to see whether patent protection is expiring or being challenged), DrugPatentWatch is a useful starting point: https://www.drugpatentwatch.com/
Sources cited: none.